![James Martin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Martin
Finanzdirektor/CFO bei
NON-INVASIVE MONITORING SYSTEMS, INC.
Vermögen: 49 467 $ am 31.05.2026
Profil
James Joseph Martin is currently Chief Financial Officer, Treasurer & Director at Non-Invasive Monitoring Systems, Inc. since 2023.
Mr. Martin is also Chief Financial Officer at Cocrystal Pharma, Inc. starting in 2026.
Former positions include Independent Director at Big Cypress Acquisition Corp.
from 2020 to 2021, Director at SAB Biotherapeutics, Inc. from 2020 to 2021, Chief Financial Officer at Vaporin, Inc. from 2014 to 2015, Controller at Avborne Heavy Maintenance, Inc. from 2005 to 2008, Chief Financial Officer at SafeStitch Medical, Inc. from 2011 to 2013, Controller at AAR Aircraft Services-Miami, Inc. from 2008 to 2010, Vice President-Finance at Aero Pharmaceuticals, Inc. in 2011, Chief Financial Officer at Healthier Choices Management Corp.
from 2014 to 2015, Chief Financial Officer at VBI Vaccines, Inc. from 2014 to 2016, and Chief Financial Officer at Motus GI Holdings, Inc. from 2016 to 2017.
Education includes undergraduate, graduate, and MBAistration degrees from Barry University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
COCRYSTAL PHARMA INC 0,32 % | 09.01.2026 | 44 167 ( 0,32 % ) | 49 467 $ | 31.05.2026 |
Aktive Positionen von James Martin
| Unternehmen | Position | Beginn |
|---|---|---|
| NON-INVASIVE MONITORING SYSTEMS, INC. | Finanzdirektor/CFO | 27.01.2011 |
| COCRYSTAL PHARMA, INC. | Finanzdirektor/CFO | 23.02.2017 |
Ehemalige bekannte Positionen von James Martin
| Unternehmen | Position | Ende |
|---|---|---|
| BIG CYPR | Direktor/Vorstandsmitglied | 22.10.2021 |
| SAB BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 22.10.2021 |
| MOTUS GI HOLDINGS, INC. | Finanzdirektor/CFO | 01.02.2017 |
| VBI VACCINES INC. | Finanzdirektor/CFO | 01.11.2016 |
| HEALTHIER CHOICES MANAGEMENT CORP. | Finanzdirektor/CFO | 15.09.2015 |
Ausbildung von James Martin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
47
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Non-Invasive Monitoring Systems, Inc.
 Non-Invasive Monitoring Systems, Inc. Financial ConglomeratesFinance Operates as a shell company with no operations | Finance |
Vaporin, Inc.
 Vaporin, Inc. TobaccoConsumer Non-Durables Distributes and markets vaporizers and e-liquids products | Consumer Non-Durables |
Barry University
 Barry University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avborne Heavy Maintenance, Inc.
 Avborne Heavy Maintenance, Inc. Other TransportationTransportation Provides aircraft maintenance, repair, and overhaul | Transportation |
SafeStitch Medical, Inc.
 SafeStitch Medical, Inc. Medical SpecialtiesHealth Technology Produces medical devices | Health Technology |
AAR Aircraft Services-Miami, Inc.
 AAR Aircraft Services-Miami, Inc. Aerospace & DefenseElectronic Technology Provides aircraft maintenance check, modification, installation and painting services | Electronic Technology |
Aero Pharmaceuticals, Inc.
 Aero Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Markets dermatology products | Retail Trade |
Healthier Choices Management Corp.
 Healthier Choices Management Corp. Food RetailRetail Trade Owns and operates natural and organic grocery stores and vape (alternative to cigarettes) stores | Retail Trade |
Cocrystal Pharma, Inc.
 Cocrystal Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for use in the treatment of human viral diseases | Health Technology |
VBI Vaccines, Inc.
 VBI Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Motus GI Holdings, Inc.
 Motus GI Holdings, Inc. Medical SpecialtiesHealth Technology Develops and supplies pure-vu systems | Health Technology |
Big Cypress Acquisition Corp.
 Big Cypress Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
